Device Trauma

Na

Payments companies reported to CMS as associated with Na. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$25Massociated payments (2023-2025)

17,271clinicians with associated payments

29companies reporting

By year

2023 $7.2M

2024 $6.9M

2025 $10M

Payments reported as associated with Na, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Trauma $8.5M

Orthopaedic Surgery $7.5M

Sports Medicine (Orthopaedic Surgery) $992K

Plastic Surgery $958K

Gastroenterology (Internal Medicine) $858K

Oral and Maxillofacial Surgery $786K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Na

These are the largest totals companies reported as associated with Na. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
George Haidukewych	Orlando, FL	Orthopaedic Surgery	$2,608,283.29
Frank Liporace	Jersey City, NJ	Orthopaedic Trauma	$1,799,850.56
Cory Collinge	Fort Worth, TX	Orthopaedic Trauma	$1,757,350.26
Bruce Ziran	Lawrenceville, GA	Orthopaedic Trauma	$1,733,820.34
Sean Nork	Seattle, WA	Orthopaedic Trauma	$1,591,666.06
Thomas Higgins	Salt Lake City, UT	Orthopaedic Surgery	$814,137.03
Matthew Graves	Jackson, MS	Orthopaedic Surgery	$812,220.51
David Carr Locke	New York, NY	Gastroenterology (Internal Medicine)	$809,748.72
Michael Gardner	Stanford, CA	Orthopaedic Trauma	$785,398.53
Chad Gordon	Baltimore, MD	Plastic Surgery	$715,802.86

Prescribed Na?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.